Avi Ma'ayan, PhD
About Me
Dr. Ma’ayan is a Mount Sinai Endowed Professor in Bioinformatics, Director of the Mount Sinai Center for Bioinformatics, Professor in the Department of Pharmacological Sciences, Professor in the Department of Artificial Intelligence and Human Health, and faculty member of the Icahn Genomics Institute. Dr. Ma'ayan is also a Principal Investigator of the NIH Common Fund Data Resource Center (DRC) for the Common Fund Data Ecosystem (CFDE), a NCI-funded ITCR resource center, a NIDDK-funded diabetes hypothesis platform, and the NCI-funded Mount Sinai Proteogenomic Data Analysis Center. The Ma'ayan Laboratory applies computational methods to study the inner workings of regulatory networks in mammalian cells. His research team applies machine learning and other statistical mining techniques to study how intracellular regulatory systems function as networks to control cellular processes such as differentiation, dedifferentiation, apoptosis and proliferation. The Ma'ayan Laboratory develops bioinformatics software applications to enable experimental biologists to form novel hypotheses from high-throughput omics datasets, while aiming to better understand the structure and function of regulatory networks in mammalian cellular and multi-cellular complex systems.
Avi Ma'ayan's Publications on PubMed | Google Scholar | ResearchGate
Featured Software Tools Developed by the Ma'ayan Laboratory:
- Rummagene: Massive mining of gene sets from supporting materials of biomedical research publications
- RummaGEO: Massive mining of gene expression signatures from the Gene Expression Omnibus (GEO)
- Playbook Workflow Builder: Interactive platform to construct bioinformatics workflows
- D2H2: Platform to facilitate data-driven hypotheses for the diabetes research community
- Enrichr: Comprehensive search engine for gene sets
- Enrichr-KG: Knowledge graph implementation of Enrichr
- Harmonizome: Uniformly processed datasets for biological knowledge discovery
- Appyters: Collection of web-based applications to execute bioinformatics workflows
- ARCHS4: Uniform alignment of all human and mouse RNA-seq samples from the Gene Expression Omnibus (GEO)
- BioJupies: Automatically generates RNA-seq data analysis notebooks
- ChEA3: ChIP-X enrichment analysis version 3
- KEA3: Kinase enrichment analysis version 3
- TargetRanger: Tool to identify cell surface immunotherapeutic targets
- GeneRanger: Expression of human genes and proteins across human cell types, tissues, and cell lines across multiple atlases
- Geneshot: Search engine for ranking genes from arbitrary text queries
- SigCom LINCS: Comprehensive search engine and data portal for selected datasets from the LINCS program
- L1000FWD: Large-scale visualization of drug-induced transcriptomic signatures
- Clustergrammer: Visualization and analyis tool for high-dimensional biological data
- lncHUB2: Functional predictions of human long non-coding RNAs based on lncRNA-gene co-expression correlations
- FAIRshake: Platform for evaluating the adherence of digital objects with the Findable, Accessible, Interoperable, and Reusable (FAIR) principles
For a complete list of bioinformatics software applications developed by the Ma'ayan Lab, please visit the Resources page.
NIH-funded Centers:
- Data Resource Center (DRC) for the Common Fund Data Ecosystem (CFDE) (2023-2028)
- Mount Sinai's Proteogenomic Data Analysis Center (PGDAC) (2022-2027)
- ARCHS4 an Informatics Technology for Cancer Research (ITCR) Resource (2022-2027)
- Diabetes Data and Hypothesis Hub (D2H2) (2022-2025)
In the News:
- Icahn School of Medicine at Mount Sinai and the University of California San Diego Receive $8.5 Million Award to Establish a Data Integration Hub for NIH Common Fund Supported Programs
- Researchers Develop AI Model to Better Predict which Drugs May Cause Birth Defects
- Genes to Potentially Diagnose Long-Term Lyme Disease Identified
- Mount Sinai Designated as National Cancer Institute Proteogenomics Data Analysis Center
- Mount Sinai Lab Creates Shared Database to Help Scientists Find Drugs That Can Be Used to Treat COVID-19
- Ten Renowned Mount Sinai Faculty Members Honored at Convocation
- Mount Sinai Researchers Develop Software to Measure the Findability, Accessibility, Interoperability, and Reusability of Biomedical Digital Research Objects
- Mount Sinai Researchers Develop Tool that Analyzes Biomedical Data within Minutes
- Mount Sinai Researchers Receive NIH Grant to Develop New Ways to Share and Reuse Research Data
- Students Harness Big Data to Help Solve Medical Challenges
- Crowdsourcing for Scientific Discovery
- Genetics: Big Hopes for Big Data
Language
Position
Research Topics
Addiction, Aging, Bioinformatics, Biomedical Sciences, Biostatistics, Cancer, Computational Biology, Diabetes, Drug Design and Discovery, Gene Expressions, Gene Regulation, Genetics, Genomics, Kidney, Mass Spectrometry, Mathematical Modeling of Biomedical Systems, Mathematical and Computational Biology, Personalized Medicine, Pharmacogenomics, Pharmacology, Protein Complexes, Protein Kinases, Proteomics, Reprogramming, Signal Transduction, Stem Cells, Systems Biology, Systems Pharmacology, Technology & Innovation, Theoretical Biology, Transcription Factors, Viruses and Virology
Multi-Disciplinary Training Areas
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Disease Mechanisms and Therapeutics (DMT), Genetics and Genomic Sciences [GGS]
About Me
Dr. Ma’ayan is a Mount Sinai Endowed Professor in Bioinformatics, Director of the Mount Sinai Center for Bioinformatics, Professor in the Department of Pharmacological Sciences, Professor in the Department of Artificial Intelligence and Human Health, and faculty member of the Icahn Genomics Institute. Dr. Ma'ayan is also a Principal Investigator of the NIH Common Fund Data Resource Center (DRC) for the Common Fund Data Ecosystem (CFDE), a NCI-funded ITCR resource center, a NIDDK-funded diabetes hypothesis platform, and the NCI-funded Mount Sinai Proteogenomic Data Analysis Center. The Ma'ayan Laboratory applies computational methods to study the inner workings of regulatory networks in mammalian cells. His research team applies machine learning and other statistical mining techniques to study how intracellular regulatory systems function as networks to control cellular processes such as differentiation, dedifferentiation, apoptosis and proliferation. The Ma'ayan Laboratory develops bioinformatics software applications to enable experimental biologists to form novel hypotheses from high-throughput omics datasets, while aiming to better understand the structure and function of regulatory networks in mammalian cellular and multi-cellular complex systems.
Avi Ma'ayan's Publications on PubMed | Google Scholar | ResearchGate
Featured Software Tools Developed by the Ma'ayan Laboratory:
- Rummagene: Massive mining of gene sets from supporting materials of biomedical research publications
- RummaGEO: Massive mining of gene expression signatures from the Gene Expression Omnibus (GEO)
- Playbook Workflow Builder: Interactive platform to construct bioinformatics workflows
- D2H2: Platform to facilitate data-driven hypotheses for the diabetes research community
- Enrichr: Comprehensive search engine for gene sets
- Enrichr-KG: Knowledge graph implementation of Enrichr
- Harmonizome: Uniformly processed datasets for biological knowledge discovery
- Appyters: Collection of web-based applications to execute bioinformatics workflows
- ARCHS4: Uniform alignment of all human and mouse RNA-seq samples from the Gene Expression Omnibus (GEO)
- BioJupies: Automatically generates RNA-seq data analysis notebooks
- ChEA3: ChIP-X enrichment analysis version 3
- KEA3: Kinase enrichment analysis version 3
- TargetRanger: Tool to identify cell surface immunotherapeutic targets
- GeneRanger: Expression of human genes and proteins across human cell types, tissues, and cell lines across multiple atlases
- Geneshot: Search engine for ranking genes from arbitrary text queries
- SigCom LINCS: Comprehensive search engine and data portal for selected datasets from the LINCS program
- L1000FWD: Large-scale visualization of drug-induced transcriptomic signatures
- Clustergrammer: Visualization and analyis tool for high-dimensional biological data
- lncHUB2: Functional predictions of human long non-coding RNAs based on lncRNA-gene co-expression correlations
- FAIRshake: Platform for evaluating the adherence of digital objects with the Findable, Accessible, Interoperable, and Reusable (FAIR) principles
For a complete list of bioinformatics software applications developed by the Ma'ayan Lab, please visit the Resources page.
NIH-funded Centers:
- Data Resource Center (DRC) for the Common Fund Data Ecosystem (CFDE) (2023-2028)
- Mount Sinai's Proteogenomic Data Analysis Center (PGDAC) (2022-2027)
- ARCHS4 an Informatics Technology for Cancer Research (ITCR) Resource (2022-2027)
- Diabetes Data and Hypothesis Hub (D2H2) (2022-2025)
In the News:
- Icahn School of Medicine at Mount Sinai and the University of California San Diego Receive $8.5 Million Award to Establish a Data Integration Hub for NIH Common Fund Supported Programs
- Researchers Develop AI Model to Better Predict which Drugs May Cause Birth Defects
- Genes to Potentially Diagnose Long-Term Lyme Disease Identified
- Mount Sinai Designated as National Cancer Institute Proteogenomics Data Analysis Center
- Mount Sinai Lab Creates Shared Database to Help Scientists Find Drugs That Can Be Used to Treat COVID-19
- Ten Renowned Mount Sinai Faculty Members Honored at Convocation
- Mount Sinai Researchers Develop Software to Measure the Findability, Accessibility, Interoperability, and Reusability of Biomedical Digital Research Objects
- Mount Sinai Researchers Develop Tool that Analyzes Biomedical Data within Minutes
- Mount Sinai Researchers Receive NIH Grant to Develop New Ways to Share and Reuse Research Data
- Students Harness Big Data to Help Solve Medical Challenges
- Crowdsourcing for Scientific Discovery
- Genetics: Big Hopes for Big Data
Language
Position
Research Topics
Addiction, Aging, Bioinformatics, Biomedical Sciences, Biostatistics, Cancer, Computational Biology, Diabetes, Drug Design and Discovery, Gene Expressions, Gene Regulation, Genetics, Genomics, Kidney, Mass Spectrometry, Mathematical Modeling of Biomedical Systems, Mathematical and Computational Biology, Personalized Medicine, Pharmacogenomics, Pharmacology, Protein Complexes, Protein Kinases, Proteomics, Reprogramming, Signal Transduction, Stem Cells, Systems Biology, Systems Pharmacology, Technology & Innovation, Theoretical Biology, Transcription Factors, Viruses and Virology
Multi-Disciplinary Training Areas
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Disease Mechanisms and Therapeutics (DMT), Genetics and Genomic Sciences [GGS]